Merck KGaA MRK StarRatingValueLabel_3Julie Utterback, CFA - Senior Equity Analyst - Morningstar Inc.

Historical Dividends
Declared DateEx DatePayment DateTypeCurrencyAmount
02/02/202429/04/202402/05/2024Cash DividendEUR2.20
07/03/202302/05/202304/05/2023Cash DividendEUR2.20
04/03/202225/04/202227/04/2022Cash DividendEUR1.85
04/03/202126/04/202128/04/2021Cash DividendEUR1.40
06/05/202029/05/202003/06/2020Cash DividendEUR1.30
07/03/201929/04/201902/05/2019Cash DividendEUR1.25
08/03/201830/04/201803/05/2018Cash DividendEUR1.25
15/03/201702/05/201704/05/2017Cash DividendEUR1.20
19/01/201602/05/201602/05/2016Cash DividendEUR1.05
27/01/201520/04/201520/04/2015Cash DividendEUR1.00
26/03/201412/05/201412/05/2014Cash DividendEUR0.95
14/04/201329/04/201329/04/2013Cash DividendEUR0.85
14/03/201223/04/201223/04/2012Cash DividendEUR0.75
11/04/201111/04/201111/04/2011Cash DividendEUR0.63
23/03/201012/04/201012/04/2010Cash DividendEUR0.50
23/02/200906/04/200906/04/2009Cash DividendEUR0.75
11/03/200831/03/200831/03/2008Cash DividendEUR0.60
11/03/200831/03/200831/03/2008Special Cash DividendEUR1.00
10/04/200730/04/200730/04/2007Cash DividendEUR0.45
10/04/200730/04/200730/04/2007Special Cash DividendEUR0.08
13/06/200603/07/200603/07/2006Cash DividendEUR0.42
12/03/200501/04/200501/04/2005Cash DividendEUR0.39
12/03/200501/04/200501/04/2005Special Cash DividendEUR0.10
09/03/200429/03/200429/03/2004Cash DividendEUR0.39
11/03/200331/03/200331/03/2003Cash DividendEUR0.49
05/03/200225/03/200225/03/2002Cash DividendEUR0.47
17/03/200106/04/200106/04/2001Cash DividendEUR0.44
22/04/200012/05/200012/05/2000Cash DividendEUR0.42
Stock Splits
Ex DateSplit FromSplit ToAdjustment Factor
30/06/20141.00002.00002.00
Julie Utterback, CFA - Senior Equity Analyst - Morningstar Inc.
The conduct of Morningstar's analysts is governed by Morningstar's Code of Ethics, Securities Trading and Disclosure Policy, and Investment Research Integrity Policy. For information regarding conflicts of interest, please click here.
Fair Value is derived from a detailed projection of a company’s future cash flows. Analysts create custom industry and company assumptions to feed income statement, balance sheet, and capital investment assumptions into a proprietary discounted cash flow modeling template. Scenario analysis, in-depth competitive advantage analysis, and a variety of other analytical tools are used to augment the discounted cash flow process. Combining analysts’ financial forecasts with the firm’s economic moat helps us assess how long returns on invested capital are likely to exceed the firm’s cost of capital. Because we are modeling free cash flow to the firm—representing cash available to provide a return to all capital providers—we discount future cash flows using the weighted average of the costs of equity, debt, and preferred stock (and any other funding sources), using expected future proportionate long-term, market-value weights. If our base-case assumptions are true the market price will converge on our fair value estimate over time, generally within three years. Investments in securities are subject to market and other risks. Past performance of a security may or may not be sustained in future and is no indication of future performance. For detail information about the Qualitative Fair Value, please click here.
© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures